21 January 2018
News and Views
Links and Services
A study in the Alimentary Pharmacology & Therapeutics published ahead of print examines rifaximin in the treatment of recurrent Clostridium difficile infection
Clostridium difficile can cause severe antibiotic-associated colitis.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors